Show simple item record

dc.contributorOsman, A.EN
dc.contributorMarghalani, M.EN
dc.contributorTurkistani, I.Y.A.EN
dc.contributorAl Swaf, M.EN
dc.contributorBin Sadiq, B.EN
dc.date.accessioned2014-06-17T08:01:23Z
dc.date.available2014-06-17T08:01:23Z
dc.date.issued2007EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/1303/13_3_2007_625_632.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/117292
dc.description625-632EN
dc.description.abstractWe carried out a retrospective descriptive study to determine prevalence and risk factors for tardive dyskinesia [‎TD]‎ among psychotic patients treated with conventional neuroleptics in 4 centres in Saudi Arabia. Records of patients who had been taking </=1 conventional neuroleptic for </= 6 months from January 1997 to December 2000 were examined; 151 patients were included in the final analysis. Only 51 had TD; another 59 [‎6.8%]‎ patients had drug-induced Parkinson disease. Duration of treatment [‎P < 0.001]‎, higher doses of neuroleptics [‎P < 0.01]‎ and age over 40 years [‎P < 0.01]‎ were associated with TD. A statistically significant difference in prevalence was found between Arabs [‎23.5%]‎ and Afro-Arabs [‎45.5%]‎ [‎P < 0.01]‎. Overall prevalence of TD among psychotic patients was 5.9%EN
dc.language.isoenEN
dc.subjectDyskinesia, Drug-InducedEN
dc.subjectAntipsychotic AgentsEN
dc.subjectArabsEN
dc.subjectRisk FactorsEN
dc.subjectRetrospective StudiesEN
dc.subject.meshDyskinesia, Drug-InducedEN
dc.titleNeuroleptic-induced tardive dyskinesia among Arab psychotic patientsEN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 13 (‎3)‎, 625-632, 2007


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record